Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study
Papp, K.A., Langley, R.G., Sigurgeirsson, B., Abe, M., Baker, D.R., Konno, P., Haemmerle, S., Thurston, H.J., Papavassilis, C., Richards, H.B.Volume:
168
Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.12110
Date:
February, 2013
File:
PDF, 580 KB
english, 2013